Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BARDA
Research
COVID antibodies shut down variants, earn $35M BARDA bucks
To “box in” SARS-CoV-2, researchers made multispecific antibodies that neutralize COVID strains and prevent the virus from evolving escape methods.
Darren Incorvaia
Oct 9, 2024 2:00pm
GigaGen garners up to $135M BARDA bucks to beat botulism
Oct 3, 2024 8:00am
Basilea scores $268M BARDA funding for antifungals, antibiotics
Sep 19, 2024 7:45am
Walgreens, BARDA ink 5-year decentralized clinical trials deal
Aug 19, 2024 10:27am
Tiba wins BARDA contract to develop RNAi flu therapeutics
Jul 11, 2024 3:35pm
Allucent selected for new BARDA decentralized trial initiative
Jul 10, 2024 5:00am
